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Perinatal/Neonatal Casebook
DENOUEMENT AND DISCUSSION Amnioinfusion as Fetal Therapy AF plays a multitude of roles in fetal growth and development. (Table  1) . Too much or too little AF volume is associated with a varying range of potentially adverse perinatal outcomes (Table 2) .
A central role for AF is apparent in fetal development and wellbeing. The volume and constituents of this most vital medium require the clinician's appreciation. AF is not simply analogous to the water in a water balloon. Acute amnioinfusion, as in the case above, is the common application of this procedure and the result of this common reasoning. 
Amnioinfusion: The Procedure
Transabdominal ultrasound is generally used when dealing with a pregnancy past 15 weeks' gestation. For the sake of easy reference, start with the patient in the dorsal supine position and make changes in positioning as dictated by the ultrasound findings. The initial bolus may range from 250 to 500 ml. As a rule, 250 ml should be used in gestations of Ͼ36 weeks. The initial rate of infusion is 150 ml/hour. If reinfusion is deemed appropriate, a similar schedule may be adhered to within the first hour.
Contraindications to infusion may be relative or absolute. We previously reported a case in which infusion was associated with a previous cesarean section scar dehiscence and cord evulsion. 1 Thus, in the presence of a vaginal birth after cesarean labor, we tend to avoid reinfusion.
The presence of oligohydramnios at term, particularly as an indication for the induction of labor, presents a difficult challenge.
For a nulligravid women, a prophylactic amnioinfusion followed by cervical ripening may enhance the rate of success in achieving vaginal delivery.
The infusion may be administered by gravity or by using a pump. Although both methodologies will work under various circumstances that seem to be related to fetal size and positioning, many prefer to use an apparatus similar to that employed in oxytocin administration. The important caveat is to use the minimum pressure required to affect a moderate flow. Ringer's solution is most commonly employed. Solutions for infusion are kept in a warmer at physiological temperatures, so that they can be administered without additional warming.
Thus, the temperature at bedside is between the ambient temperature (typically 70°F) and that originally maintained in the warmer (98.6°F).
Although a uterine resting tone within the normal range (Ͻ20 mm Hg) is desirable, amnioinfusion may be useful when abnormalities exist in this regard. Infusion should be avoided during episodes of polysystole, but after administration of tocolytics and discontinuation of oxytocin, amnioinfusion may affect a positive change in uterine activity pattern after contractions resume.
We do not, as a rule, employ prophylactic antibiotics with infusion. The risks of sensitization and the risks of pathogen-selective resistance deem the routine risk greater than the benefits. Certain circumstances may call for the therapeutic use of antibiotics, as dictated by overall assessment of the patient.
Amnioinfusion: Applications
The usual indications for amnioinfusion include the presence of thick meconium and/or FHR decelerations. When these occur in tandem, particularly when decelerations are accompanied by a rising or tachycardic baseline, amnioinfusion may prove especially valuable in the attempt to provide in utero resuscitation. As always, when evaluating and instituting therapy for presumed fetal jeopardy, the clinician should continue to re-evaluate the need for expeditious delivery. However, when temporizing may allow for a safe and timely conclusion to labor, amnioinfusion is an invaluable adjunct. 2, 3 Amnioinfusion as an aid to correcting malposition such as breech presentation is being evaluated clinically at present. 4 Perhaps the same approach will prove to beneficial in aiding the correction of malpresenting fetuses in multifetal deliveries.
Another potential avenue for the use of amnioinfusion could be as an aid in the delivery of a fetus compromised with certain anomalies, such as Potter's syndrome, or perhaps even a "stuck" twin fetus.
Amnioinfusion has other possible applications that complement its unique physiology. One intriguing situation is an application in pregnancies compromised by spontaneous premature rupture of membranes, to reconstitute volume on a chronic basis. To date, the use of multiple lumen catheters and antibiotic-laced solutions has shown only mixed results.
Dispersal of medications by AF also has had some limited use in obstetrical care. Thyroxine and digoxin are medications that have been successfully administered to the fetus by this route. Other medications, including antibiotics, antimetabolites, and immunosuppressants, have also been so used.
A further application of amnioinfusion as fetal therapy might exploit an aspect of its unique physiology to allow for excretion of undesired substances in utero. AF is markedly hypoosmolar with respect to fetal and maternal blood. This is due in part to the hypotonic urine produced by the fetus. The osmotic forces available probably play an important role in the volume regulation of intravascular blood volume in the fetus as well as in the regulation of intrauterine AF volume. It is at least hypothetically possible that this osmotic force could be used to remove toxic substrates from the fetus, either endogenous or exogenous.
As currently practiced, amnioinfusion at term is a tool that provides for limited intervention on behalf of the fetus during labor. The procedure is safe, useful, and efficacious. The potential applications 
